Invesco Biotechnology & Genome ETF (PBE) Chart & Stock Price History $65.54 +0.24 (+0.37%) Closing price 08/1/2025 04:10 PM EasternExtended Trading$65.56 +0.02 (+0.04%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Invesco Biotechnology & Genome ETF Stock Price Performance The Invesco Biotechnology & Genome ETF (PBE) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has decreased 4.28%, with a year-to-date return of -1.49%. In the past month, the fund has decreased 0.18%, reflecting recent market activity. As of the latest close, Invesco Biotechnology & Genome ETF traded at $65.54 with a market cap of $226.11 million and volume of 6,231 shares. Five years ago, the fund traded at $60.74, representing a 7.90% increase over that period. At the time, it had a market cap of $236.89 million and a volume of 5,468 shares. Receive PBE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.47%1 Month Performance-0.18%3 Month Performance+4.65%Year-To-Date Performance-1.49%1 Year Performance-4.28%5 Year Performance+7.90% PBE Stock Chart for Monday, August, 4, 2025 PBE Chart by TradingView Invesco Biotechnology & Genome ETF Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$65.30$65.54+0.37%$65.68$64.756,231 shs$226.11 million07/31/2025$65.85$65.30-0.84%$66.54$65.157,705 shs$225.29 million07/30/2025$65.93$65.85-0.12%$66.60$65.853,670 shs$227.18 million07/29/2025$65.85$65.93+0.12%$66.19$65.803,834 shs$227.46 million07/28/2025$66.59$65.85-1.11%$66.49$64.975,527 shs$227.18 million07/25/2025$66.67$66.59-0.12%$66.64$66.252,428 shs$229.74 million07/24/2025$66.78$66.67-0.16%$67.14$66.587,499 shs$230.01 million07/23/2025$65.29$66.78+2.28%$66.86$65.548,062 shs$231.73 million07/22/2025$64.00$65.29+2.02%$65.33$63.924,499 shs$226.56 million07/21/2025$64.30$64.00-0.47%$64.45$63.983,577 shs$222.08 million Get the Latest News and Ratings for PBE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$65.62$64.30-2.01%$65.73$64.302,919 shs$223.12 million07/17/2025$66.26$65.62-0.97%$66.32$65.596,423 shs$227.70 million07/16/2025$65.38$66.26+1.35%$66.28$65.414,048 shs$229.92 million07/15/2025$66.91$65.38-2.29%$65.90$65.384,709 shs$226.87 million07/14/2025$66.14$66.91+1.16%$66.91$65.875,473 shs$232.85 million07/11/2025$67.31$66.14-1.74%$66.79$66.143,055 shs$230.17 million07/10/2025$66.70$67.31+0.91%$67.40$66.823,272 shs$234.24 million07/09/2025$65.19$66.70+2.32%$66.70$66.028,810 shs$232.12 million07/08/2025$64.53$65.19+1.02%$65.50$64.426,625 shs$226.86 million07/07/2025$65.66$64.53-1.72%$65.34$64.305,381 shs$224.56 million07/04/2025$65.66$65.66$65.72$65.522,487 shs$229.15 million07/03/2025$65.43$65.66+0.35%$65.72$65.522,487 shs$229.15 million Related Companies PJP Stock Chart XHE Stock Chart CURE Stock Chart XPH Stock Chart PSCH Stock Chart PINK Stock Chart BBH Stock Chart KURE Stock Chart PTH Stock Chart XHS Stock Chart Receive PBE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:PBE) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredWall Street Laughed. Now They're Buying.For six months, I’ve been pounding the table on a major gold miner—while Twitter pundits laughed. But now, the...Golden Portfolio | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Biotechnology & Genome ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
